Your browser is no longer supported. Please, upgrade your browser.
PFE Pfizer Inc. weekly Stock Chart
Pfizer Inc.
IndexDJIA S&P500 P/E13.47 EPS (ttm)2.72 Insider Own0.03% Shs Outstand5.55B Perf Week-2.69%
Market Cap202.95B Forward P/E12.65 EPS next Y2.89 Insider Trans-8.72% Shs Float5.53B Perf Month0.27%
Income15.42B PEG3.16 EPS next Q0.57 Inst Own75.00% Short Float0.89% Perf Quarter6.15%
Sales53.04B P/S3.83 EPS this Y-11.90% Inst Trans-0.08% Short Ratio2.50 Perf Half Y-12.10%
Book/sh11.74 P/B3.12 EPS next Y-2.39% ROA10.10% Target Price41.45 Perf Year-17.03%
Cash/sh1.64 P/C22.33 EPS next 5Y4.27% ROE26.30% 52W Range33.97 - 46.47 Perf YTD-16.15%
Dividend1.44 P/FCF60.51 EPS past 5Y1.00% ROI10.20% 52W High-21.24% Beta0.65
Dividend %3.93% Quick Ratio0.70 Sales past 5Y0.80% Gross Margin80.30% 52W Low7.74% ATR0.53
Employees92400 Current Ratio0.90 Sales Q/Q-4.60% Oper. Margin36.70% RSI (14)44.14 Volatility1.27% 1.38%
OptionableYes Debt/Eq0.81 EPS Q/Q98.20% Profit Margin30.60% Rel Volume1.23 Prev Close36.97
ShortableYes LT Debt/Eq0.55 EarningsOct 29 BMO Payout48.70% Avg Volume19.61M Price36.60
Recom2.50 SMA20-1.59% SMA50-0.02% SMA200-8.49% Volume24,656,692 Change-1.00%
Oct-17-19Resumed BofA/Merrill Neutral $37
Jul-30-19Downgrade Morgan Stanley Overweight → Equal-Weight $48 → $40
Jul-30-19Downgrade BofA/Merrill Buy → Neutral
Jun-04-19Resumed Morgan Stanley Overweight $48
Feb-20-19Resumed Citigroup Neutral $41
Jan-31-19Upgrade Credit Suisse Neutral → Outperform
Jan-31-19Upgrade Argus Hold → Buy
Jan-23-19Downgrade UBS Buy → Neutral
Dec-11-18Downgrade JP Morgan Overweight → Neutral
Nov-01-18Downgrade BMO Capital Markets Outperform → Market Perform
Jun-08-18Initiated Cantor Fitzgerald Overweight $45
Apr-05-18Downgrade Barclays Overweight → Equal Weight $41 → $38
Jan-29-18Reiterated SunTrust Hold $33 → $40
Sep-20-17Upgrade Morgan Stanley Equal-Weight → Overweight
Jul-20-17Downgrade Credit Suisse Outperform → Neutral
May-16-17Downgrade Citigroup Neutral → Sell
Dec-02-16Initiated Guggenheim Neutral
Nov-02-16Downgrade Argus Buy → Hold
Oct-13-16Downgrade Jefferies Buy → Hold
Jun-20-16Reiterated Jefferies Buy $42 → $40
Nov-13-19 03:43PM  UPDATE 1-J&J blockbuster loses ground to biosimilars despite Quebec court ruling Reuters
09:30AM  Abbott Labs Chooses an Insider to Be Its New CEO
03:23AM  CENTOGENE Signs Data Access and Collaboration Agreement with Pfizer Inc. GlobeNewswire
01:00AM  J&J's Remicade losing ground in Quebec health plan despite court victory Reuters
Nov-12-19 12:15PM  Mylan and Pfizer Announce Viatris as the New Company Name in the Planned Mylan-Upjohn Combination PR Newswire
06:45AM  Pfizer Announces Results of Phase 3 Study for XELJANZ® (tofacitinib) in Juvenile Idiopathic Arthritis Ahead of Presentation at 2019 American College of Rheumatology/Association of Rheumatology Professionals Annual Meeting Business Wire
Nov-11-19 04:23PM  Pfizer-Merck KGaA's Bavencio Fails in 2nd Gastric Cancer Study Zacks
10:16AM  Walgreens' stock surge providing a 25-point cushion to the Dow's price MarketWatch
Nov-08-19 08:41AM  Merck KGaA, Pfizer drug fails to meet endpoints in gastric cancer trial MarketWatch
08:00AM  Merck and Pfizer Provide Update on Phase III JAVELIN Gastric 100 Trial CNW Group
08:00AM  EMD Serono and Pfizer Provide Update on Phase III JAVELIN Gastric 100 Trial PR Newswire
Nov-07-19 02:20PM  David Carlson Trims Charles Schwab, Exits Verizon
10:51AM  Aerie (AERI) Q3 Loss Wider, Sales Beat, Guidance Slashed Zacks
05:32AM  [video]Pfizer's Long-Term Outlook Is Murky, Says UBS on Lowering Price Target
Nov-06-19 09:20AM  Pfizer Beats Earnings as Weekly Chart Stays Positive Investopedia
Nov-05-19 01:12PM  Coury on Mylan merger: 'We're moving the company to something quite different" American City Business Journals
12:37PM  Mylan shares slide 5.5% as CFRA downgrades to sell from hold MarketWatch
11:41AM  Mylan's (MYL) Q3 Earnings Beat Estimates, Revenues Miss Zacks
11:01AM  Which Companies Recently Raised Guidance? Yahoo Finance
09:27AM  Mylan Doles Out the Right Prescription for Investors
09:00AM  AbbVie Stock Is Poised To Become A Top 5 Pharma But Should You Buy It? Investor's Business Daily
07:27AM  UPDATE 3-Mylan shares slide after warning of hit to revenue Reuters
07:07AM  Mylan tops profit estimates as newer drugs spur North America growth Reuters
07:07AM  Mylan shares slide after warning of hit to revenue Reuters
Nov-04-19 12:28PM  Marine algae keys Chinese claim to Alzheimers breakthrough MarketWatch
11:10AM  The Zacks Analyst Blog Highlights: Pfizer, Merck, Bristol-Myers and Glaxo Zacks
10:01AM  5 Large-Cap Stocks Are Up More Than 100% This Year
01:00AM  Rounding Up Big Pharma Earnings Morningstar
Nov-01-19 02:16PM  The Good, Bad, and Ugly for Biogen Stock InvestorPlace
11:55AM  Pharma Stock Roundup: MRK, PFE, GSK, BMY Q3 Earnings, Other Updates Zacks
Oct-31-19 11:48AM  European agency highlights blood clot risks from Pfizer's arthritis drug Reuters
11:45AM  Exelixis (EXEL) Q3 Earnings Beat on Strong Cabometyx Sales Zacks
11:37AM  Bristol-Myers' (BMY) Q3 Earnings & Revenues Beat Estimates Zacks
11:27AM  Glaxo (GSK) Beats Q3 Earnings Estimates, Raises '19 EPS View Zacks
10:57AM  A Closer Look At Pfizer Inc.'s (NYSE:PFE) Impressive ROE Simply Wall St.
05:00AM  Small biotech Pinteon eyes large goal: a treatment for Alzheimer's American City Business Journals
Oct-30-19 04:41PM  Edited Transcript of PFE earnings conference call or presentation 29-Oct-19 2:00pm GMT Thomson Reuters StreetEvents
12:17PM  Pfizer Stock Is A Top Pharma Company But Should You Buy It? Investor's Business Daily
10:47AM  Stock Market News For Oct 30, 2019 Zacks
10:43AM  Healthcare ETFs Win in October: Here's Why Zacks
09:52AM  Decision Day: Fed On Tap Later, Followed by Apple, Facebook After Close Benzinga
09:20AM  Why would the Fed cut interest rates a 3rd time in a row even as stocks near records? Investors may soon find out MarketWatch
09:00AM  Pfizer's Latest Move Points to 14% Upside Ahead
07:23AM  GLOBAL MARKETS-Fed and $50bln auto merger plan temper share price pullback Reuters
Oct-29-19 06:10PM  US Indexes Close Lower Tuesday After 4-Day Rally
05:06PM  GLOBAL MARKETS-Stocks falter, dollar slips on potential U.S.-China trade delay Reuters
04:31PM  Dow Jones Today: Struggling at the Highs InvestorPlace
04:24PM  Dow Jones Holds 27,000 Level As Pfizer, Merck Soar On Earnings Investor's Business Daily
04:19PM  S&P 500 retreats from record high; Google miss weighs on tech shares MarketWatch
04:08PM  How Pfizer Shocked Investors After A New Drug Obliterated Expectations Investor's Business Daily
03:17PM  Stocks Retreat From Record Highs Tuesday
03:13PM  Stock Market Eases Despite Solid Earnings; These Two Drug Giants Buoy The Dow Investor's Business Daily
12:41PM  US STOCKS-S&P 500 hits record high on robust Merck, Pfizer earnings Reuters
12:41PM  Pfizer to become smaller, science-based company following Mylan deal American City Business Journals
11:35AM  US STOCKS-S&P 500 squeezes higher on robust Merck, Pfizer earnings Reuters
10:52AM  US STOCKS SNAPSHOT-Merck, Pfizer spur S&P 500 to record high; Alphabet weighs on Nasdaq Reuters
10:38AM  US STOCKS-S&P 500 flat on mixed earnings reports; Alphabet weighs on Nasdaq Reuters
10:38AM  Strong Q3 Earnings Data Deluge Zacks
10:26AM  Q3 Earnings Bonanza: GM, MRK, MA & More Zacks
10:12AM  Merck and Pfizer Stocks Are on a Roll as Earnings Beat Forecasts, Raise Hope About Big Pharma
10:06AM  A bear-market catalyst is lying in wait for stocks, warns UBS MarketWatch
10:03AM  Pfizer (PFE) Rises on Q3 Earnings & Sales Beat, Ups EPS View Zacks
09:56AM  Dow Jones Today: Stocks Turn Mixed As Merck, Pfizer Rise; Alphabet Undercuts Buy Point Investor's Business Daily
08:45AM  US STOCKS-Wall Street set for subdued open on mixed earnings reports Reuters
08:31AM  Merck, Pfizer stock gains on earnings beats would add 23 points to the Dow's price MarketWatch
08:08AM  Pfizer Stock Is Getting a Lift Because Things Are a Lot Better Than Wall Street Thought
08:05AM  Pfizer (PFE) Beats Q3 Earnings and Revenue Estimates Zacks
07:52AM  S&P 500 flat on mixed earnings reports; Alphabet weighs on Nasdaq Reuters
07:37AM  Pfizer results boosted by innovative drugs and EM growth Financial Times
07:04AM  Pfizer raises 2019 forecast on surging cancer drug sales Reuters
06:57AM  Pfizer shares jump premarket as earnings beat estimates and company raises guidance MarketWatch
03:19AM  Pfizer Tops Q3 Earnings Forecast, Boosts Full Year Profit Guidance: Shares Gain
Oct-28-19 03:06PM  Pfizer's Q3 Earnings Preview Benzinga
11:59AM  Drug/Biotech Stock Q3 Earnings Due on Oct 29: MRK, PFE & More Zacks
09:45AM  Microsoft, Goldman Sachs share gains lead Dow's 183-point jump MarketWatch
07:48AM  Apple, Facebook and Exxon are about to lead a big test of the earnings recession MarketWatch
06:30AM  Pfizer Reports Earnings Tomorrow. Heres What to Expect.
Oct-27-19 12:56PM  The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings Benzinga
Oct-24-19 10:16AM  Pfizer (PFE) to Report Q3 Earnings: What's in the Cards? Zacks
Oct-23-19 05:04PM  'Fast Money Halftime Report' Traders Weigh In On Salesforce, Pfizer And More Benzinga
Oct-22-19 02:15PM  Fitbit Stock Needs a Viable Growth Narrative for Q3 InvestorPlace
Oct-21-19 05:45PM  Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know Zacks
11:00AM  What's in Store for Healthcare ETFs in Q3 Earnings? Zacks
09:16AM  What to expect from the landmark opioid trial Yahoo Finance Video
08:21AM  Opko and Pfizer announce positive results in late-stage trial of human growth hormone treatment MarketWatch
08:00AM  OPKO and Pfizer Announce Positive Phase 3 Top-Line Results for Somatrogon, an Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency GlobeNewswire
06:55AM  TIMELINE-Popular heartburn medicine Zantac pulled off store shelves Reuters
Oct-18-19 11:23AM  The Zacks Analyst Blog Highlights: Johnson & Johnson, Boeing, Pfizer, Qualcomm and Mitsubishi UFJ Financial Zacks
10:21AM  Factors Setting the Tone for Novartis' (NVS) Q3 Earnings Zacks
Oct-17-19 04:00PM  Top Stock Reports for Johnson & Johnson, Boeing & Pfizer Zacks
10:54AM  Can New Drugs Help Lilly (LLY) to Deliver Solid Q3 Earnings? Zacks
09:30AM  PFE vs. NVO: Which Stock Is the Better Value Option? Zacks
09:28AM  Fitbit stock gains after company announces biotech partnership MarketWatch
09:00AM  Fitbit's plan to beat Apple in personal health Yahoo Finance
Oct-16-19 04:28AM  Viagra Inventor Raises Funds to Test AI-Generated Treatments Bloomberg
Oct-15-19 03:37PM  Health savings accounts provide benefits, tax advantages Yahoo Finance Video
12:37PM  Top 4 Mutual Fund Holders of Pfizer Investopedia
Oct-14-19 05:45PM  Pfizer (PFE) Gains As Market Dips: What You Should Know Zacks
03:59PM  Johnson and Johnson Stock Still Significantly Undervalued InvestorPlace
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases under the Lyrica, Chantix/Champix, Eliquis, Ibrance, Sutent, Xalkori, Inlyta, Xtandi, Enbrel, Xeljanz, Eucrisa, BeneFix, Genotropin, and Refacto AF/Xyntha brands. The company also provides consumer healthcare products that comprise over-the-counter medicines, including dietary supplement products under the Centrum, Caltrate, and Emergen-C names; pain management products under the Advil and ThermaCare names; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H names; and respiratory and personal care products under the Robitussin, Advil Cold & Sinus, and ChapStick names. In addition, it offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, Viagra, Inflectra/Remsima, Zyvox, Vfend, Revatio, Inspra, Medrol, Sulperazon, Fragmin, Tygacil, Nivestim, and Retacrit, Ixifi Infliximab BS names. Further, the company is also involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., and Oncolytics Biotech Inc.; licensing agreement with BionTech AG; strategic alliance with Verily Life Sciences LLC; and collaboration agreements with Pfizer, Merck & Co., Inc., and Eli Lilly & Company, as well as Merck KGaA, Nektar Therapeutics, and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PFIZER INC10% OwnerSep 17Buy18.0050,000900,0004,593,847Sep 19 04:19 PM
Gottlieb ScottDirectorAug 23Buy34.723,000104,1603,000Aug 26 09:27 AM
DAMELIO FRANK AExecutive Vice PresidentJul 02Sale44.09153,1846,753,385337,392Jul 03 04:06 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentJun 20Sale44.0030,0001,320,00080,094Jun 21 04:08 PM
PFIZER INC10% OwnerMay 13Buy17.0050,000850,0003,249,973May 14 07:34 AM
MACKENZIE ALEXANDER RExecutive Vice PresidentApr 01Sale42.8315,000642,503110,094Apr 02 03:05 PM
JOHNSON RADY AExecutive Vice PresidentMar 15Sale41.138,700357,83159,797Mar 18 06:37 PM
Dolsten MikaelPresident R&DMar 04Sale43.5249,0822,136,293289,126Mar 05 04:54 PM
ROGERS DAWNExecutive Vice PresidentMar 04Sale42.9815,002644,79814,920Mar 05 04:55 PM
READ IAN CExecutive ChairmanMar 04Sale43.2950,7882,198,4741,639,280Mar 06 04:03 PM
READ IAN CExecutive ChairmanMar 04Sale43.17530,07822,882,7021,109,202Mar 06 04:03 PM
SUSMAN SALLYExecutive Vice PresidentMar 04Sale43.268,725377,444172,094Mar 06 03:29 PM
SUSMAN SALLYExecutive Vice PresidentMar 04Sale43.1463,9982,760,698108,096Mar 06 03:29 PM
Dolsten MikaelPresident R&DMar 01Option Exercise31.34106,1913,328,057438,679Mar 05 04:54 PM
Dolsten MikaelPresident R&DMar 01Sale43.56100,4714,376,852338,208Mar 05 04:54 PM
ROGERS DAWNExecutive Vice PresidentFeb 27Option Exercise32.2319,297621,94245,049Mar 01 07:47 PM
SUSMAN SALLYExecutive Vice PresidentFeb 27Option Exercise32.2385,7632,764,141228,743Mar 01 07:47 PM
YOUNG JOHN DGroup PresidentFeb 27Option Exercise32.23154,3744,975,474441,923Mar 01 07:47 PM
GOETTLER MICHAELGroup PresidentFeb 27Option Exercise32.2330,017967,44848,652Mar 01 07:37 PM
Hwang AngelaGroup PresidentFeb 27Option Exercise32.2311,792380,05623,635Mar 01 07:37 PM
JOHNSON RADY AExecutive Vice PresidentFeb 27Option Exercise32.2330,017967,44881,341Mar 01 07:37 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 27Option Exercise32.2364,3222,073,098123,145Mar 01 07:37 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 27Option Exercise32.2381,4752,625,939416,278Mar 01 07:37 PM
BOURLA ALBERTChief Executive OfficerFeb 27Option Exercise32.2364,3222,073,098331,982Mar 01 07:29 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 27Option Exercise32.2325,729829,246121,743Mar 01 07:29 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 27Option Exercise32.23182,2475,873,821588,177Mar 01 07:29 PM
YOUNG JOHN DGroup PresidentFeb 23Option Exercise21.0343,724919,516312,403Feb 26 07:45 PM
JOHNSON RADY AExecutive Vice PresidentFeb 23Option Exercise21.0318,004378,62461,182Feb 26 07:45 PM
BOURLA ALBERTChief Executive OfficerFeb 23Option Exercise21.0336,008757,248191,438Feb 26 07:45 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 23Option Exercise21.0387,4491,839,052388,024Feb 26 07:45 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 23Option Exercise21.03185,1853,894,441522,576Feb 26 07:45 PM
SUSMAN SALLYExecutive Vice PresidentFeb 23Option Exercise21.0397,7372,055,409205,833Feb 26 07:46 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 23Option Exercise21.0343,724919,51683,781Feb 26 07:45 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 23Option Exercise21.0341,615875,163144,164Feb 26 07:10 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 23Option Exercise21.0330,864649,070115,139Feb 26 07:10 PM
ROGERS DAWNExecutive Vice PresidentFeb 23Option Exercise21.0319,290405,66937,638Feb 26 07:10 PM
GOETTLER MICHAELGroup PresidentFeb 23Option Exercise21.0319,290405,66931,507Feb 26 07:11 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 01Sale42.755,000213,75040,057Feb 01 07:21 PM
Dolsten MikaelPresident R&DJan 31Option Exercise29.78125,9683,751,425362,051Feb 01 07:28 PM
LANKLER DOUGLAS MExecutive Vice PresidentJan 30Sale41.1938,8001,598,07145,057Feb 01 07:21 PM